Kadimastem Obtains US Patent for Neurodegenerative Disease Stem Cell Technology – Multiple Sclerosis News Today
Multiple Sclerosis News Today |
Kadimastem Obtains US Patent for Neurodegenerative Disease Stem Cell Technology
Multiple Sclerosis News Today The United States has granted a patent to Kadimastem's stem cell-based technology for treating multiple sclerosis (MS) and other diseases of the nervous system. The patent involves the technology the company used to produce supporting cells in the … |
